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Abstract
Background: Age-related macular degeneration (AMD) is the main cause of blindness in the developed world. The etiology
of AMD is multifactorial due to the interaction between genetic and environmental factors. IL-8 has a role in inflammation
and angiogenesis; we report the genetic characterization of IL-8 allele architecture and evaluate the role of SNPs or
haplotypes in the susceptibility to wet AMD, case-control study.
Methods: Case-control study including 721 AMD patients and 660 controls becoming from Italian population. Genotyping
was carried out by Real Time-PCR. Differences in the frequencies were estimated by the chi-square test. Direct sequencing
was carried out by capillary electrophoresis trough ABI3130xl.
Results: rs2227306 showed a p-value of  4.15*1025 and an Odds Ratio (OR) for T allele of 1.39 [1.19–1.62]. After these
positive results, we sequenced the entire IL-8 regulatory and coding regions of 60 patients and 30 controls stratified for their
genotype at rs2227306. We defined two different haplotypes involving rs4073 (A/T), rs2227306 (C/T), rs2227346 (C/T) and
rs1126647 (A/T): A-T-T-T (p-value: 2.08*1029; OR: 1.68 [1.43–1.97]) and T-C-C-A (p-value: 7.07*10211; OR: 0.60 [0.51–0.70]). To
further investigate a potential functional role of associated haplotypes, we performed an expression study on RNA extracted
from whole blood of 75 donors to verify a possible direct correlation between haplotype and gene expression, failing to
reveal significant differences.
Conclusions: These results suggest a possible secondary role of IL-8 gene in the development of the disease. This paper
outlines the importance of association between inflammation and AMD. Moreover IL-8 is a new susceptibility genomic
biomarker of AMD.
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Introduction
Age-related macular degeneration (AMD), the main cause of
blindness in the developed world, affects more than one million
Italian people. The etiology of AMD is multifactorial due to the
interaction between genetic and environmental factors. As with
other complex diseases, recent genome-wide studies have estab-
lished and confirmed many genetic variants associated with higher
risk for AMD.[1,2] Genetic and functional studies have confirmed
that inflammation plays a pivotal role in the pathogenesis and
progression of AMD. Above all, C-reactive protein has been
associated with AMD [3,4] as well as different interleukin genes,
including IL-6 [3] and IL-8. [5,6] Despite this, the genomics of
certain interleukin pathways in AMD is poorly understood,
probably due to their small effect on overall susceptibility, which
may lead to false negative findings in genome-wide association
studies (GWAS). Interleukins mediate many of the effector phases
of immune and inflammatory responses. In addition, activated
macrophages secrete many proteolysis enzymes, such as collage-
nases and elastases, which may fragment Bruch’s membrane and
promote the neovascularization typical of wet AMD. The
interindividual variability, in terms of quality and quantity of
cytokines produced, is associated with single nucleotide polymor-
phisms (SNPs) and copy number variations (CNVs) involving
promoters, introns, exons, and regulatory elements. [7–9] Inter-
leukin-8, a member of the CXC chemokine family, is a
chemoattractant of neutrophils and lymphocytes. IL-8 encodes a
protein that mediates effects by interacting with two cell-surface G
protein-coupled receptors, CXCR1 and CXCR2. [10,11] A wide
variety of cells can express IL-8 with the principal role of initiating
PLOS ONE | www.plosone.org 1 June 2013 | Volume 8 | Issue 6 | e66978
and amplifying acute inflammatory reactions.[12] Additionally,
IL-8 plays a pivotal role in cancer pathogenesis, including
angiogenesis, tumor growth, and metastasis.[13] Despite its role
in inflammation and angiogenesis, little is known about the effects
of IL-8 genetic variants in the development of wet AMD.[6] Here,
we report the genetic characterization of IL-8 allele architecture
and evaluate the role of SNPs or haplotypes in the susceptibility to
wet AMD through a well-powered, case-control study.
Materials and Methods
Ethics Statement
The study was conducted according to the Declaration of
Helsinki, and informed consent was obtained from the participat-
ing subjects after the nature of the study had been explained. The
study protocol was approved by the ethics committee of the
University of Rome Tor Vergata, Rome, Italy.
Patients’ recruitment
The 1381 Italian subjects recruited for this study were classified
in two different groups: patients diagnosed with exudative AMD
(case group, n= 721) and subjects clinically evaluated as not
having any form of macular degeneration (control group, n= 660).
The Medical Retina Centre of Policlinico of Tor Vergata in Rome
provided a thorough clinical evaluation of case and control groups,
and all subjects were included in the study according to criteria
explained in Ricci et al.[14] The same inclusion criteria were used
from the other centre involved in our study: the Eye Clinic,
Department of Clinical Science ‘‘Luigi Sacco’’ in Milan and the
Department of Clinical Physiopathology, Eye Clinic, University of
Torino. Clinical data collected were age at diagnosis, bilaterality,
family history, and CNV (choroidal neovascularization) type
(Table 1). Furthermore a questionnaire on environmental factors
was submitted to patients and controls recruited to assess their
smoke habits. All patients and controls were sex matched.
Genetic analysis
Genotyping. We first evaluated the association of an intronic
SNP in the IL-8 gene: rs2227306. Genotyping was performed by
TaqMan assays (Applied Biosystems, Foster City, California).
Reactions were run in an AB7500 Fast real-time PCR machine
(Applied Biosystems) and interpreted using Sequence Detection
System 2.1 software (Applied Biosystems). Each plate contained
three positive control samples previously confirmed by direct
sequencing and a negative control sample. No departure from
Hardy-Weinberg equilibrium was detected. Results from genotype
assessment were confirmed by direct sequencing of 10 random
samples.
Table 1. Clinical characteristics of samples tested.
Characteristic Patients with AMD (n:721) Healthy control subjects (n:660)
Age, year: range 52–91 53–88
Age, year: mean (SD) 75.0 (7.6) 69.2 (11.1)
Sex: man (%) 324 (45) 304 (46)
Sex: woman (%) 397 (55) 356 (54)
Family history of AMD (%) 397 (55) NA
CNV: classic (%) 325 (45) NA
CNV: occult (%) 396 (55) NA
Bilatelar neovascular AMD (%) 72 (10) NA
Age at diagnosis, mean (SD) 74.3 (7.9) NA
Smoke habits: never 362 (50.2) 516 (78.2)
Smoke habits: ex smoker 213 (29.6) NA
Smoke habits: smoker 146 (20.2) 144 (21.8)
NA: not applicable.
doi:10.1371/journal.pone.0066978.t001
Table 2. Primers used for IL8 sequencing.
IL8 region Forward Primer (59-39) Reverse Primer (59-39)
Length of
amplicon Annealing Temperature
Promoter GACAAGTACCTAGTCTTATC CTGAAAGTTTGTGCCTTATG 685 56u
Exon1 AGTGTGATGACTCAGGTTTG GAATAGCTTTGCTATCTAAGG 368 58u
Exon2 AGGAAGTAGCTGGCAGAGCT TTCTCCACAACCCTCTGCAC 545 62u
CTTTCTGATGGAAGAGAGCT TATTGCATCTGGCAACCCTA 627 58u
GATGCCAGTGAAACTTCAAG TCACAACATCACTGTGAGGT 543 58u
AAGTCCTTGTTCCACTGTGC TGACTGTGGAGTTTTGGCTG 546 60u
TCCTAGTTTGATACTCCCAG GCTAAGGGGAAGCATTTATG 425 58u
cDNA ACAAGCTTCTAGGACAAGAG ATGAATTCTCAGCCCTCTTC 315 58u
doi:10.1371/journal.pone.0066978.t002
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Sequencing. We sequenced the entire genomic sequence of
IL-8, including the promoter region, in 60 cases and 30 controls.
Direct sequencing was performed through seven different
amplicons: one for the promoter, one for exon 1, and five for
exon 2 (Table 2). PCR was performed using AmpliTaq Gold DNA
Polymerase (Applied Biosystems) according to the manufacturer’s
instructions. PCR products were purified, and PCR sequence
reactions were performed with BigDye Terminator v3.1. After
purification with BigDyeXTerminator (Applied Biosystems), sam-
ples were run on an ABI3130xl (Applied Biosystems). We also
sequenced the entire genomic sequence and the cDNA sequence
of the 75 subjects recruited for the expression study (see Table 2
for primers).
Expression study
Real-time PCR. The generation of first-strand cDNA was
performed using a high capacity DNA reverse transcription kit
(Applied Biosystems) according to the manufacturer’s instructions.
The reverse transcriptase reaction products were used for
quantitative real-time PCR, which was run in an AB7500 (Applied
Biosystems) using TaqMan predesigned probes (Hs00174103_m1).
The amount of IL-8 mRNA present in each sample was
normalized to the amount of mRNA of the HPRT reference gene
in the same sample. Relative mRNA expression levels of all
examined genes were measured using the comparative 22DDCT
method. Each plate contained a negative control.
Statistical analysis
Statistical analyses were performed by a standard 262 table and
Fisher’s exact tests. Allele and genotype frequencies of all the
variations tested were compared with those of the clinically
examined control subjects (n = 660). Allele analysis in unrelated
samples was performed using the software UNPHASED [15]. The
ORs were calculated by the online software ‘‘Calculator for
Confidence Intervals of Odds Ratio in an Unmatched Case
Control Study’’ [16]. The binary logistic regression has been
carried out by SPSS Program (SSPS Inc., IL, USA).
Results
We tested the association between rs2227306 and wet AMD in
a discovery cohort composed of 362 cases and 660 controls
(Table 3). We obtained a significant p-value when we compared
allele frequencies between cases and controls (p=0.001). The T
allele of rs2227306 achieved an odds ratio (OR) of 1.38 (95%
CI= 1.14–1.67). We confirmed these findings in a replication
cohort of patients (n = 359) and obtained the same level of
association (p=0.001) and a comparable OR (1.40; 95%
CI= 1.16–1.69). In the merged cluster of samples, composed of
both discovery and replication cohorts (n = 721), we obtained a p-
value of 4.1561025 and an OR of 1.39 (95% CI=1.19–1.62) for
the T allele. As expected, genotype association confirmed these
findings (Table 4). No differences in allele frequencies were
detected after phenotype stratification (classic vs occult cnv, data
not shown).
On the basis of these positive preliminary results, we sequenced
the entire IL-8 regulatory and coding regions to understand the
allele architecture of the gene and to identify causative SNPs or
haplotypes. From 90 samples, including 20 cases for each
genotypic class of rs2227306 and 30 controls, we detected two
different conserved genomic regions in subjects carrying the T or
C allele of rs2227306. The conserved regions involved three
different SNPs: rs2227306 (C/T), rs2227346 (C/T), and
rs1126647 (A/T). Complete linkage disequilibrium (D9=1) was
detected between each SNP. Through sequencing, we defined two
haplotypes: CCA and TTT. The associated haplotypes cover the
promoter of a gene tagged by the marker rs4073 (A/T), although
some recombination has been observed in both cases and controls
(5% and 4%, respectively; Table 5). The small fraction of
recombination makes it difficult to obtain a clear interpretation
Table 3. Allelic association of rs2227306.
Cohort Risk allele AMD (Counts and frequency) (n:721) Controls (Counts and frequency) (n: 660) P OR (95% CI)
I: n:362 T 281 (0.39) 416 (0.08) 0.001 1.38 (1.14–1.67)
II: n:359 T 281 (0.39) 416 (0.08) 0.001 1.40 (1.16–1.69)
I + II: n:721 T 562 (0.39) 416 (0.08) 4.15*1025 1.39 (1.19–1.62)
doi:10.1371/journal.pone.0066978.t003
Table 4. Genotypic association of rs2227306.
Cohort Genotype AMD (Counts and frequency) (n:721) Controls (Counts and frequency) (n: 660) P OR (95% CI)
I: n:362 CC 142 (0.39) 308 (0.46) 0.002 0.74 (0.57–0.97)
CT 159 (0.44) 288 (0.44) 1.20 (0.91–1.58)
TT 61 (0.17) 64 (0.10) 2.07 (1.38–3.10)
II: n: 359 CC 133 (0.37) 308 (0.46) 0.002 0.67 (0.52–0.88)
CT 171 (0.48) 288 (0.44) 1.38 (1.04–1.81)
TT 55 (0.15) 64 (0.10) 1.99 (1.32–3.01)
I + II: n: 721 CC 275 (0.38) 308 (0.46) 3.55*1025 0.70 (0.57–0.87)
CT 330 (0.46) 288 (0.44) 1.28 (1.02–1.61)
TT 116 (0.16) 64 (0.10) 2.03 (1.44–2.87)
doi:10.1371/journal.pone.0066978.t004
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of recombinant haplotypes to disclose or exclude causative effects
of single SNPs. To further investigate a potential functional role of
associated haplotypes, we performed an expression study on RNA
extracted from whole blood of 75 donors to verify the existence of
a direct correlation between haplotype and gene expression. Of
the tested samples, 25 were homozygous for haplotype T-C-C-A,
25 were homozygous for haplotype A-T-T-T, and 25 were
heterozygous for rs2227306. We failed to detect differences in the
expression of IL-8 among these different haplotype and genotype
classes. To investigate a potential role of the associated haplotypes
on splicing and/or post-trascriptional regulation we also rese-
quenced the cDNA of these subjects but failed to reveal any
sequence differences.
We performed a binary logistic regression considering the two
haplotypes (T-C-C-A and A-T-T-T) and the smoke habit as
independent variables and the status case/control as dependent
variables. The contribution of smoke is statistically significant
(p,0.0001) showing an OR[Exp(B)] of 3.424 (CI 95% 2.036–
5.758). The multivariate logistic regression was carried out also to
investigate the impact of age on the disease. Despite the significant
association between age and disease (p = 0.001), the OR[Exp(B)]
was 1.062 (CI 95% 1.024–1.102).
Discussion
In this study, we identified two haplotypes associated with the
development of AMD and confirmed these findings in two
independent sample cohorts, including 721 patients and 660
controls. Functional studies failed to reveal a role of these
haplotypes on mRNA expression and splicing. Taken together,
these results confirm a role for IL-8 in AMD pathogenesis. Despite
its role in inflammation and angiogenesis, little is known about the
effects of IL-8 genetic variants in the development of AMD and
further studies are needed to better understand its biological role
in the pathogenesis of the disease. [17–20] It is well known that
most of visual loss occurs in the late stages of the disease due to one
of two processes: neovascular (wet) age-related macular degener-
ation and geographic atrophy (‘‘late dry’’). Genetic background of
AMD confirm these aspects as the large majority of genes
associated to its development are involved in inflammation
regulation, most notably complement Factor H.[21] The IL-8
gene, located on chromosome 4q12–q13, encodes for the most
potent chemokine known and responsible for inducing chemotax-
is, which is the directed migration of cells to a site of
inflammation.[22] This chemokine is important in the regulation
of the inflammatory response for its ability to recruit and activate
acute inflammatory cells. It is also able to mediate the activation
and migration of neutrophil also involved in the pathogenesis of
disease. [23].
It is notably that in human coronary atherosclerosis, IL-8 is an
important mediator of angiogenesis and may contribute to plaque
formation via its angiogenic properties. [24] In this context IL-8
could represent a candidate gene to link the development and
progression of AMD, the smoke habits and the occurrence of
cardiovascular events in these patients. Oxidative stress has been
shown to promote IL-8 production in several cell types. ROS
(reactive oxygen species) can activate transduction pathways such
as mitogen-activated protein kinases that contribute to the
production of pro-inflammatory cytokines such as (IL)-8. The
dysregulation of IL-8 balance can lead to the type of serious tissue
damage that has been reported in several diseases such IBD
(Inflammatory Bowel Disease), severe asthma and in patients with
active colitis [25–26].
Oxidative stress and inflammation are interrelated. Whereas
oxidative stress triggers inflammatory responses and inflammation
also enhances the production of reactive oxygen species. It is to
notice that recent works indicate that oxidative inactivation of the
proteasome is a mechanistic link between oxidative stress and
increased production of IL-8 in cultured RPE. [27–29] While
further studies will be needed to assess the pathogenic role of IL8
and its receptors in the development of AMD, the strength of
genetic association of IL8 here reported, suggest that IL-8 SNPs
should be included in the subset of variations to be tested to
calculate individual risk for developing AMD. [30–34].
Acknowledgments
This work was supported by the ‘‘Macula & Genoma Foundation-onlus’’.
We are very grateful to all the staff of the Centre of Excellence for Genomic
risk Assessment in Multifactorial and Complex Diseases, School of
Medicine, University of Rome ‘‘Tor Vergata’’ for their effort in our study.
Author Contributions
Conceived and designed the experiments: FR GS EG GN. Performed the
experiments: TL SZ RC. Analyzed the data: PB EG. Contributed
reagents/materials/analysis tools: FM LTM CME AC FR GS. Wrote the
paper: FR GS EG. Phenotyping of patients: FM CME AC FR GS.
References
1. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, et al. (2010)
Genetic variants near TIMP3 and high-density lipoprotein-associated loci
influence susceptibility to age-related macular de generation. Proc Natl Acad Sci
USA 107: 7401–6.
2. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, et al. (2010) Genome-
wide association study of advanced age-related macular degeneration identifies a
role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 107: 7395–7400.
3. Seddon JM, George S, Rosner B, Rifai N (2005) Progression of age-related
macular degeneration: prospective assessment of C-reactive protein, interleukin
6, and other cardiovascular biomarkers. Arch Ophthalmol 123: 774–782.
Table 5. Frequencies and association of haplotypes involving rs4073 (A/T), rs2227306 (C/T), rs2227346 (C/T) and rs1126647 (A/T).
Haplotypes Cases frequencies Control frequencies P OR (95% CI)
A-C-C-A 0.05 0 NA NA
A-T-T-T 0.39 0.28 2.08*1029 1.68 (1.43–1.97)
T-C-C-A 0.56 0.68 7.07*10211 0.60 (0.51–0.70)
T-T-T-T 0 0.04 NA NA
NA: not applicable.
doi:10.1371/journal.pone.0066978.t005
Haplotypes in IL-8 Gene Are Associated to AMD
PLOS ONE | www.plosone.org 4 June 2013 | Volume 8 | Issue 6 | e66978
4. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N (2004) Association
between C-reactive protein and age-related macular degeneration. JAMA 291:
704–710.
5. Goverdhan SV, Ennis S, Hannan SR, Madhusudhana KC, Cree AJ, et al.
(2008) Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-
related macular degeneration. Br J Ophthalmol 92: 537–540.
6. Tsai YY, Lin JM, Wan L, Lin HJ, Tsai Y, et al. (2008) Interleukin gene
polymorphisms in age-related macular degeneration. Invest Ophthalmol Vis Sci
49: 693–8.
7. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, et al. (1998) The
effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6
transcription and plasma IL-6 levels, and an association with systemic-onset
juvenile chronic arthritis. J Clin Invest 102: 1369–1376.
8. Kroeger KM, Carville KS, Abraham LJ (1997) The2308 tumor necrosis factor-
alpha promoter polymorphism effects transcription. Mol Immunol 34: 391–9.
9. Warle´ MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, et al. (2003) Are
cytokine gene polymorphisms related to in vitro cytokine production profiles?
LiverTranspl 9: 170–181.
10. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI (1991) Structure and
functional expression of a human interleukin-8 receptor. Science 253: 1278–
1280.
11. Murphy PM, Tiffany HL (1991) Cloning of complementary DNA encoding a
functional human interleukin-8 receptor. Science 253: 1280–1283.
12. Wu GD, Lai EJ, Huang N, Wen X (1997) Oct-1 and CCAAT/Enhancer-
binding Protein (C/EBP) Bind to Overlapping Elements within the Interleukin-8
Promoter. J Biol Chem 272: 2396–2403.
13. Gao LB, Pan XM, Jia J, Liang WB, Rao L, et al. (2010) IL-8 -251A/T
polymorphism is associated with decreased cancer risk among population-based
studies: evidence from a meta-analysis. Eur J Cancer 46: 1333–1343.
14. Ricci F, Zampatti S, D9Abbruzzi F, Missiroli F, Martone C, et al. (2009) Typing
of ARMS2 and CFH in age-related macular degeneration: case-control study
and assessment of frequency in the Italian population. Arch Ophthalmol 127:
1368–1372.
15. Laboratory for Interdisciplinary Technologies in Bioinformatics website.
Available: http://www.litbio.org. Accessed 2012 Apr 5.
16. Calculator for Confidence Intervals of Odds Ratio in an Unmatched Case
Control Study website. Available: http://www.hutchon.net/confidor.htm.
Accessed 2013 Feb 15.
17. Ve´gran F, Boidot R, Michiels C, Sonveaux P, Feron O (2011) Lactate influx
through the endothelial cell monocarboxylate transporter MCT1 supports an
NF-kB/IL-8 pathway that drives tumor angiogenesis. Cancer Res 71: 2550–
2560.
18. Ning Y, Manegold PC, Hong YK, Zhang W, Pohl A, et al. (2011) Interleukin-8
is associated with proliferation, migration, angiogenesis and chemosensitivity in
vitro and in vivo in colon cancer cell line models. Int J Cancer 128: 2038–2049.
19. Matsuo Y, Ochi N, Sawai H, Yasuda A, Takahashi H, et al. (2009) CXCL8/IL-
8 and CXCL12/SDF-1alpha co-operatively promote invasiveness andangiogen-
esis in pancreatic cancer. Int J Cancer 124: 853–861.
20. Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, et al. (2007) Interleukin-8
is a molecular determinant of androgen independence and progression in
prostate cancer. Cancer Res. 67: 6854–6862.
21. Telander DG (2011) Inflammation and age-related macular degeneration
(AMD). Semin Ophthalmol 26: 192–7.
22. Remick DG, (2005) Interleukin-8. Critical Care Medicine 33(12 Suppl.):S466–7.
23. Andia DC, Letra A, Casarin RC, Casati MZ, Line SR, et al. (2012) Genetic
analysis of the IL8 gene polymorphism (rs4073) in generalized aggressive
periodontitis. Arch Oral Biol.
24. Simonini A, Moscucci M, Muller DW, Bates ER, Pagani FD, et al. (2000) IL-8 is
an angiogenic factor in human coronary atherectomy tissue. Circulation
101(13):1519–26.
25. MacDermott RP, (1999) Chemokines in the inflammatory bowel diseases. J Clin
Immunol. 5: 266–72.
26. Nakagome K, Matsushita S, Nagata M (2012) Neutrophilic inflammation in
severe asthma. Int Arch Allergy Immunol.;158 Suppl 1: 96–102.
27. Zhou J, Jang YP, Kim SR, Sparrow JR (2006) Complement activation by
photooxidation products of A2E, a lipofuscin constituent of the retinal pigment
epithelium. Proc. Natl. Acad. Sci.USA 103: 16182–16187.
28. Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, et al. (2008)
Oxidativedamage-inducedinflam-mationinitiatesage-relatedmaculardegenera-
tion. Nat.Med 14: 194–198.
29. Fernandes AF, Zhou J, Zhang X, Bian Q, Sparrow J, et al. (2008) Oxidative
inactivation of the proteasome in retinal pigment epithelial cells. A potential link
between oxidative stress and up-regulation of inter-leukin-8. J. Biol.Chem. 283:
20745–20753.
30. Yu Y, Reynolds R, Rosner B, Daly MJ, Seddon JM (2012) Prospective
Assessment of Genetic Effects on Progression to Different Stages of Age-related
Macular Degeneration Using Multi-state Markov Models. Invest Ophthalmol
Vis Sci 53: 1548–56.
31. Spencer KL, Glenn K, Brown-Gentry K, Haines JL, Crawford DC (2012)
Population differences in genetic risk for age-related macular degeneration and
implications for genetic testing. Arch Ophthalmol 130: 116–7.
32. Klein R, Klein BE, Myers CE (2011) Risk assessment models for late age-related
macular degeneration. Arch Ophthalmol 129: 1605–6.
33. Rennie CA, Stinge A, King EA, Sothirachagan S, Osmond C, Lotery AJ (2012)
Can genetic risk information for age-related macular degeneration influence
motivation to stop smoking? A pilot study. Eye (Lond) 26: 109–118.
34. Seddon JM, Reynolds R, Yu Y, Daly MJ, Rosner B (2011) Risk models for
progression to advanced age-related macular degeneration using demographic,
environmental, genetic, and ocular factors. Ophthalmology 118: 2203–2211.
Haplotypes in IL-8 Gene Are Associated to AMD
PLOS ONE | www.plosone.org 5 June 2013 | Volume 8 | Issue 6 | e66978
